Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
5.99
-0.09 (-1.56%)
At close: May 9, 2025, 4:00 PM
6.09
+0.10 (1.75%)
After-hours: May 9, 2025, 7:02 PM EDT
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
$1,088,459
Profits / Employee
-$58,864
Market Cap
1.84B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
FOLD News
- 4 days ago - Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference - GlobeNewsWire
- 10 days ago - Amicus Therapeutics, Inc. (FOLD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 11 days ago - Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States - GlobeNewsWire
- 20 days ago - Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewsWire
- 7 weeks ago - Amicus Therapeutics Is Very Attractive At Current Prices (Rating Upgrade) - Seeking Alpha
- 2 months ago - In NCLA Amicus Win, D.C. Circuit Recognizes President Trump's Right to Fire Principal Officer - GlobeNewsWire
- 2 months ago - NCLA Amicus Brief Asks Fifth Circuit to Maintain Block Against Corporate Transparency Act - GlobeNewsWire